Rapid Diagnostic Testing for HIV:
Clinical Implications of a New Diagnostic Tool
REFERENCES
1. UNAIDS/WHO. AIDS epidemic update. UNAIDS and WHO. December, 2003.
2. Steinbrook, R. The AIDS Epidemic in 2004. New England Journal of Medicine 2004; 351: 115-7.
3. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2002. http://www.cdc.gov/hiv/stats/addendum.htm
4. Centers for Disease Control and Prevention. Diagnoses of HIV/AIDS --- 32 States, 2000—2003. MMWR 2004 December 3; 53:1107-1110. http://www.cdc.gov/mmwr/PDF/wk/mm5347.pdf
5. New Jersey Department of Health and Senior Services. New Jersey HIV/AIDS [Surveillance] Report, June 30, 2004. http://www.state.nj.us/health/aids/qtr0306.pdf
6. Centers for Disease Control and Prevention. Incorporating HIV Prevention into the Medical Care of Persons Living with HIV: Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003 July 18:52(RR12): 1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm
7. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing and referral and revised recommendations for HIV screening of pregnant women. MMWR 2001:50(No RR-19), 11/09/2001 http://www.cdc.gov/mmwr/PDF/RR/RR5019.pdf
8. Truong, H-H M and Klausner, JD. Diagnostic Assays for HIV-1 infection. MLO 2004:36 no. 7: 12-20.
9. Centers for Disease Control and Prevention. Number of Persons Tested for HIV - United States, 2002 MMWR 2004 December 3; 53:1110-1113. http://www.cdc.gov/mmwr/PDF/wk/mm5347.pdf
10. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing and referral and revised recommendations for HIV screening of pregnant women. MMWR 2001:50(No RR-19), 11/09/2001 http://www.cdc.gov/mmwr/PDF/RR/RR5019.pdf
11. Centers for Disease Control and Prevention. Update: HIV Counseling and Testing Using Rapid Tests – United States, 1995. MMWR 1998; 47; 211-215.
12. Paul S, Burr C, DiFerdinando G. Updated Recommendations for Reducing Vertical HIV Transmission. New Jersey Medicine. 2003 (Supplement); 100: 27-31.
13. Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States - June 23, 2004 www.hivatis.org
14. Wade NA, Birkhead GS, Warren BL et al. Abbreviated regimen of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. NEJM 1998:339:1409-1414.
15. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795-802.
16. Centers for Disease Control and Prevention. Rapid Point-of-Care Testing for HIV-1 During Labor and Delivery — Chicago, Illinois, 2002. 2003; 28:149-151.
17. Centers for Disease Control and Prevention. Rapid HIV antibody testing during labor and delivery for women of unknown HIV status: A practical guide and model. 2004. www.cdc.gov/hiv/projects/perinatal.
18. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for post exposure prophylaxis. MMWR 2001; 50 (No RR-11): 1-53. http://www.cdc.gov/mmwr/PDF/RR/RR5011.pdf
19. Paul S. Reducing the Risk of Occupational HIV Transmission. New Jersey Medicine. 2003(Supplement); 100:15-20
20. Tokars JL et al. Surveillance of HIV infection and Zidovudine use among healthcare workers after occupational exposure to HIV infected blood. A Intern Med 1993:118:913-919.
21. Centers for Disease Control and Prevention Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States: Recommendations from the U.S. Department of Health and Human Services. MMWR. 2005:54 (RR02); 1-20.) January 21, 2005. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm
22. Centers for Disease Control and Prevention. Routinely Recommended HIV Testing at an Urban Urgent-Care Clinic --- Atlanta, Georgia 2000. MMWR 2001:50(25): 538-541.
23. Branson, B. Update on HIV Rapid Tests. Perinatal HIV Prevention, Grantee Meeting. Atlanta, GA, February 27-28, 2001.
24. Centers for Disease Control and Prevention. Interpretation and the Use of the Western Blot Assay for Serodiagnosis of Human Immunodeficiency Virus Type 1 Infections. MMWR 1989:38(suppl. 7): S4-S6
25. National Alliance of State and Territorial AIDS Directors (NASTAD). Letter to the FDA Requiring Expedited Approval of Rapid HIV Tests. May 18, 2000. NASTAD
26. Branson, B. Point-of-Care Rapid Tests for HIV Antibody. Journal of Laboratory Medicine 2003:27(7/8): 288-295
|
